AblaCare System for Polycystic Ovary Syndrome
This trial is testing a new system for transvaginal ablation of ovarian tissue in women with PCOS who have not responded to other treatments.
- Polycystic Ovary Syndrome
- Female Infertility
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many participants are engaging in this experiment?
"Yes, the information on clinicialtrials.gov attests that this research effort is presently enrolling participants. The investigation was initially posted in May 12th 2022 and had its last update 5 weeks later on July 5th 2022. Five individuals are required to be recruited from a single medical center."
Are there any vacancies left in the research program?
"Indeed, clinicaltrials.gov reports that recruitment for this study is still underway. It was first posted on May 12th 2022 and updated most recently on July 5th 2022. At the moment, the team behind it needs to find 5 participants from a single medical site."
Does this research endeavor include individuals aged over fifty-five in its pool of subjects?
"This medical trial has set the age of eligibility at 18 to 40 years old. However, there are alternate trials for patients who do not meet this criteria; 401 studies catering to minors and 1019 for older people over 65."
May I apply to participate in this research program?
"This medical trial is open to five sterile females between the ages of 18 and 40. For enrollment, individuals must fulfill a variety of prerequisites including: WHO 2010 parameters for sperm concentration (≥ 15 million/mL) and motility (≥ 40%), normal morphology (> 4%), ultrasonographic evidence or hyperandrogenaemia, ovarian volume ≥ 10ml, patency in at least one fallopian tube within three years prior to submission date, willingness to comply with study requirements as outlined by the Clinical Investigation Plan-specified follow-up evaluation, fluency in an IRB approved written language translation of the Patient Information and Informed"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Oklahoma: < 48 hours
Average response time
- < 2 Days